BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28300864)

  • 1. Whole exome sequencing in the Framingham Heart Study identifies rare variation in HYAL2 that influences platelet aggregation.
    Eicher JD; Chen MH; Pitsillides AN; Lin H; Veeraraghavan N; Brody JA; Metcalf GA; Muzny DM; Gibbs RA; Becker DM; Becker LC; Faraday N; Mathias RA; Yanek LR; Boerwinkle E; Cupples LA; Johnson AD
    Thromb Haemost; 2017 Jun; 117(6):1083-1092. PubMed ID: 28300864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).
    Eicher JD; Xue L; Ben-Shlomo Y; Beswick AD; Johnson AD
    J Thromb Thrombolysis; 2016 Feb; 41(2):343-50. PubMed ID: 26519038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome-chip meta-analysis identifies association between variation in ANKRD26 and platelet aggregation.
    Chen MH; Yanek LR; Backman JD; Eicher JD; Huffman JE; Ben-Shlomo Y; Beswick AD; Yerges-Armstrong LM; Shuldiner AR; O'Connell JR; Mathias RA; Becker DM; Becker LC; Lewis JP; Johnson AD; Faraday N
    Platelets; 2019; 30(2):164-173. PubMed ID: 29185836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation.
    Kim Y; Suktitipat B; Yanek LR; Faraday N; Wilson AF; Becker DM; Becker LC; Mathias RA
    PLoS One; 2013; 8(5):e64179. PubMed ID: 23704978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Feng D; Lindpaintner K; Larson MG; O'Donnell CJ; Lipinska I; Sutherland PA; Mittleman M; Muller JE; D'Agostino RB; Levy D; Tofler GH
    Circulation; 2001 Jul; 104(2):140-4. PubMed ID: 11447076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.
    Johnson AD; Yanek LR; Chen MH; Faraday N; Larson MG; Tofler G; Lin SJ; Kraja AT; Province MA; Yang Q; Becker DM; O'Donnell CJ; Becker LC
    Nat Genet; 2010 Jul; 42(7):608-13. PubMed ID: 20526338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study.
    Feng D; Lindpaintner K; Larson MG; Rao VS; O'Donnell CJ; Lipinska I; Schmitz C; Sutherland PA; Silbershatz H; D'Agostino RB; Muller JE; Myers RH; Levy D; Tofler GH
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1142-7. PubMed ID: 10195947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α2A-Adrenergic receptor polymorphism potentiates platelet reactivity in patients with stable coronary artery disease carrying the cytochrome P450 2C19*2 genetic variant.
    Peace AJ; Mangiacapra F; Bailleul E; Delrue L; Dierickx K; Conte M; Puymirat E; Fraeymans AL; Meeus P; Bartunek J; Volpe M; Barbato E
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1314-9. PubMed ID: 24723553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel genetic variants associated with short stature in a Baka Pygmies population.
    Zoccolillo M; Moia C; Comincini S; Cittaro D; Lazarevic D; Pisani KA; Wit JM; Bozzola M
    Hum Genet; 2020 Nov; 139(11):1471-1483. PubMed ID: 32583022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study).
    Puurunen MK; Hwang SJ; Larson MG; Vasan RS; O'Donnell CJ; Tofler G; Johnson AD
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and environmental contributions to platelet aggregation: the Framingham heart study.
    O'Donnell CJ; Larson MG; Feng D; Sutherland PA; Lindpaintner K; Myers RH; D'Agostino RA; Levy D; Tofler GH;
    Circulation; 2001 Jun; 103(25):3051-6. PubMed ID: 11425767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
    Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
    Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults.
    Lindkvist M; Fernberg U; Ljungberg LU; Fälker K; Fernström M; Hurtig-Wennlöf A; Grenegård M
    Thromb Res; 2019 Feb; 174():5-12. PubMed ID: 30543988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of platelet aggregation in African Americans.
    Qayyum R; Becker LC; Becker DM; Faraday N; Yanek LR; Leal SM; Shaw C; Mathias R; Suktitipat B; Bray PF
    BMC Genet; 2015 May; 16():58. PubMed ID: 26024889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.
    Molica F; Morel S; Meens MJ; Denis JF; Bradfield PF; Penuela S; Zufferey A; Monyer H; Imhof BA; Chanson M; Laird DW; Fontana P; Kwak BR
    Thromb Haemost; 2015 Aug; 114(2):325-36. PubMed ID: 25947940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency.
    Fasham J; Lin S; Ghosh P; Radio FC; Farrow EG; Thiffault I; Kussman J; Zhou D; Hemming R; Zahka K; Chioza BA; Rawlins LE; Wenger OK; Gunning AC; Pizzi S; Onesimo R; Zampino G; Barker E; Osawa N; Rodriguez MC; Neuhann TM; Zackai EH; Keena B; Capasso J; Levin AV; Bhoj E; Li D; Hakonarson H; Wentzensen IM; Jackson A; Chandler KE; Coban-Akdemir ZH; Posey JE; Banka S; Lupski JR; Sheppard SE; Tartaglia M; Triggs-Raine B; Crosby AH; Baple EL
    Genet Med; 2022 Mar; 24(3):631-644. PubMed ID: 34906488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
    Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases].
    Sirotkina OV; Zabotina AM; Berkovich OA; Bazhenova EA; Vavilova TV; Shvartsman AL
    Genetika; 2009 Feb; 45(2):247-53. PubMed ID: 19334620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.
    Hetherington SL; Singh RK; Lodwick D; Thompson JR; Goodall AH; Samani NJ
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):252-7. PubMed ID: 15514209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.